Purpose
to assess the safety of dolutegravir based antiretroviral therapy and HIV prevention products in pregnancy by establishing a National Pregnancy Exposure Registry across 3 provinces in South Africa
Grantee
Division
Global Health
Date
APRIL 2020
Region served
AFRICA
Committed amount
$900,000
Grant topic
HIV
Duration (months)
30
Grantee location
Parktown, Gauteng, South Africa
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.